[Quantitative changes in the cellular makeup of the spleen in mice infected with the Rauscher leukemia virus and Brucella abortus]. 1979

N I Belianchikova, and T K Veskova, and K L Chimishkian, and L P Trubcheninova, and G Ia Svet-Moldavskiĭ

Changes in the absolute number of splenic cells of mice infected with Rauscher leukemia virus (RLV) and a day later--with living Brucella (BA) were studied. The increase in the absolute number of splenic cells of mice infected with RLV + BA was initially caused by the lymphoid tissue reaction to Brycella and then by the development of leukemia. The number of reticular cells in the spleen appeared to be larger than the control (RLV) within all observation periods; the number of basophilic normocytes amounted to the control, but an increase in the erythroblasts number was noted a week later and reached the control level by the 30th day, practically being unchanged subsequently. In mice receiving RLV + BA there was the increased monocyte, plasmatic cell, megakaryocyte, myeloid series cell count. The shift of splenic granulocytes to the "left", the development of leukocytosis, blood neutrophilia, in particular, lagged 1--2 weeks behind in such mice. The number of normocytes getting into the blood was decreased. All this would result in a significant extension of the lifespan in mice RLV + BA.

UI MeSH Term Description Entries
D007942 Leukemia, Experimental Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues. Experimental Leukemia,Experimental Leukemias,Leukemia Model, Animal,Leukemias, Experimental,Animal Leukemia Model,Animal Leukemia Models,Leukemia Models, Animal
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D011925 Rauscher Virus A strain of MURINE LEUKEMIA VIRUS associated with mouse tumors similar to those caused by the FRIEND MURINE LEUKEMIA VIRUS. It is a replication-competent murine leukemia virus. It can act as a helper virus when complexing with a defective transforming component, RAUSCHER SPLEEN FOCUS-FORMING VIRUS. Rauscher leukemia virus,Rauscher leukemia viruses,Virus, Rauscher,leukemia viruses, Rauscher
D002003 Brucella abortus A species of the genus BRUCELLA whose natural hosts are cattle and other bovidae. Abortion and placentitis are frequently produced in the pregnant animal. Other mammals, including humans, may be infected. Bacterium abortus,Brucella melitensis biovar abortus
D002004 Brucella Vaccine A bacterial vaccine for the prevention of brucellosis in man and animal. Brucella abortus vaccine is used for the immunization of cattle, sheep, and goats. Vaccine, Brucella
D002006 Brucellosis Infection caused by bacteria of the genus BRUCELLA mainly involving the MONONUCLEAR PHAGOCYTE SYSTEM. This condition is characterized by fever, weakness, malaise, and weight loss. Malta Fever,Undulant Fever,Brucella Infection,Brucellosis, Pulmonary,Cyprus Fever,Gibraltar Fever,Rock Fever,Brucella Infections,Brucelloses,Brucelloses, Pulmonary,Fever, Cyprus,Fever, Gibraltar,Fever, Malta,Fever, Rock,Fever, Undulant,Infection, Brucella,Pulmonary Brucelloses,Pulmonary Brucellosis
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.

Related Publications

N I Belianchikova, and T K Veskova, and K L Chimishkian, and L P Trubcheninova, and G Ia Svet-Moldavskiĭ
May 1974, Journal of the National Cancer Institute,
N I Belianchikova, and T K Veskova, and K L Chimishkian, and L P Trubcheninova, and G Ia Svet-Moldavskiĭ
January 1976, Journal of surgical oncology,
N I Belianchikova, and T K Veskova, and K L Chimishkian, and L P Trubcheninova, and G Ia Svet-Moldavskiĭ
January 1972, Archiv fur die gesamte Virusforschung,
N I Belianchikova, and T K Veskova, and K L Chimishkian, and L P Trubcheninova, and G Ia Svet-Moldavskiĭ
December 1970, Infection and immunity,
N I Belianchikova, and T K Veskova, and K L Chimishkian, and L P Trubcheninova, and G Ia Svet-Moldavskiĭ
November 1967, Applied microbiology,
N I Belianchikova, and T K Veskova, and K L Chimishkian, and L P Trubcheninova, and G Ia Svet-Moldavskiĭ
January 1976, Voprosy virusologii,
N I Belianchikova, and T K Veskova, and K L Chimishkian, and L P Trubcheninova, and G Ia Svet-Moldavskiĭ
January 1976, Journal of surgical oncology,
N I Belianchikova, and T K Veskova, and K L Chimishkian, and L P Trubcheninova, and G Ia Svet-Moldavskiĭ
April 1977, Cancer research,
N I Belianchikova, and T K Veskova, and K L Chimishkian, and L P Trubcheninova, and G Ia Svet-Moldavskiĭ
August 1972, Cancer research,
N I Belianchikova, and T K Veskova, and K L Chimishkian, and L P Trubcheninova, and G Ia Svet-Moldavskiĭ
January 1978, Acta biologica et medica Germanica,
Copied contents to your clipboard!